CN1188159C - 一种治疗冠心病室性早搏的药物组合物及制备方法 - Google Patents
一种治疗冠心病室性早搏的药物组合物及制备方法 Download PDFInfo
- Publication number
- CN1188159C CN1188159C CNB02146572XA CN02146572A CN1188159C CN 1188159 C CN1188159 C CN 1188159C CN B02146572X A CNB02146572X A CN B02146572XA CN 02146572 A CN02146572 A CN 02146572A CN 1188159 C CN1188159 C CN 1188159C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- portions
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002861 ventricular Effects 0.000 title claims abstract description 18
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 title claims abstract description 10
- 229940079593 drug Drugs 0.000 title claims abstract description 7
- 239000000203 mixture Substances 0.000 title abstract description 8
- 208000000418 Premature Cardiac Complexes Diseases 0.000 title abstract 2
- 241000208340 Araliaceae Species 0.000 claims abstract description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 19
- 235000008434 ginseng Nutrition 0.000 claims abstract description 19
- 210000000582 semen Anatomy 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 241001489978 Eupolyphaga Species 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 206010003119 arrhythmia Diseases 0.000 abstract description 9
- 230000006793 arrhythmia Effects 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 239000002775 capsule Substances 0.000 abstract description 5
- 230000001502 supplementing effect Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 4
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 abstract description 2
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 abstract description 2
- 229940039750 aconitine Drugs 0.000 abstract description 2
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000747 cardiac effect Effects 0.000 abstract description 2
- 230000033764 rhythmic process Effects 0.000 abstract description 2
- 235000014722 Aralia cordata Nutrition 0.000 abstract 1
- 244000294554 Aralia racemosa Species 0.000 abstract 1
- 235000004446 Aralia racemosa Nutrition 0.000 abstract 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 235000014066 European mistletoe Nutrition 0.000 abstract 1
- 241001506304 Kadsura japonica Species 0.000 abstract 1
- 235000010658 Lavandula latifolia Nutrition 0.000 abstract 1
- 241001448421 Ophiopogon jaburan Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000152640 Rhipsalis cassutha Species 0.000 abstract 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 235000011148 calcium chloride Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 239000009636 Huang Qi Substances 0.000 description 8
- 230000008602 contraction Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002028 premature Effects 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 230000036284 oxygen consumption Effects 0.000 description 3
- LPMXVESGRSUGHW-UHFFFAOYSA-N Acolongiflorosid K Natural products OC1C(O)C(O)C(C)OC1OC1CC2(O)CCC3C4(O)CCC(C=5COC(=O)C=5)C4(C)CC(O)C3C2(CO)C(O)C1 LPMXVESGRSUGHW-UHFFFAOYSA-N 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- LPMXVESGRSUGHW-GHYGWZAOSA-N Ouabain Natural products O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1)[C@H]1C[C@@H](O)[C@@]2(CO)[C@@](O)(C1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)C[C@@H](O)[C@H]21 LPMXVESGRSUGHW-GHYGWZAOSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 244000166550 Strophanthus gratus Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000000890 drug combination Substances 0.000 description 2
- 239000010135 fructus aurantii immaturus Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 2
- 229960003343 ouabain Drugs 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000009877 shengmai Substances 0.000 description 2
- 235000006793 Artemisia stelleriana Nutrition 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 102000006996 Aryldialkylphosphatase Human genes 0.000 description 1
- 108010008184 Aryldialkylphosphatase Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 240000005308 Juniperus chinensis Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000006413 coastal sagewort Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 208000003663 ventricular fibrillation Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB02146572XA CN1188159C (zh) | 2002-10-24 | 2002-10-24 | 一种治疗冠心病室性早搏的药物组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB02146572XA CN1188159C (zh) | 2002-10-24 | 2002-10-24 | 一种治疗冠心病室性早搏的药物组合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1403148A CN1403148A (zh) | 2003-03-19 |
CN1188159C true CN1188159C (zh) | 2005-02-09 |
Family
ID=4751112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB02146572XA Expired - Lifetime CN1188159C (zh) | 2002-10-24 | 2002-10-24 | 一种治疗冠心病室性早搏的药物组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1188159C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010009573A1 (zh) * | 2008-07-23 | 2010-01-28 | 河北以岭医药研究院有限公司 | 心肌细胞钾离子通道调节药物组合物及其制备方法和应用 |
CN101874869B (zh) * | 2009-04-28 | 2012-02-08 | 河北以岭医药研究院有限公司 | 一种中药组合物中马钱苷的含量测定方法 |
CN101632784B (zh) * | 2008-07-21 | 2012-09-05 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗急性心梗药物中的应用 |
CN105928365A (zh) * | 2016-05-05 | 2016-09-07 | 武汉拓材科技有限公司 | 一种用于高纯材料制备的石英器皿渗碳装置及方法 |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100486451C (zh) * | 2006-08-18 | 2009-05-13 | 山东师范大学 | 一种地鳖酱及其制作方法 |
CN101190307B (zh) * | 2006-11-28 | 2010-05-12 | 浙江爱生药业有限公司 | 治疗充血性心力衰竭的中药复方制剂 |
CN101313990B (zh) * | 2007-06-01 | 2011-12-07 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗神经官能症药物中的应用 |
CN101391021B (zh) * | 2007-09-20 | 2012-04-18 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗焦虑症药物中的应用 |
CN101396521B (zh) * | 2007-09-28 | 2011-11-09 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备联合管通治疗低血压脑供血不足药物中的应用 |
CN101406613B (zh) * | 2007-10-11 | 2011-11-09 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗病毒性心肌炎药物中的应用 |
CN101411814B (zh) * | 2007-10-19 | 2011-08-10 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗心室内传导阻滞的药物中的应用 |
CN101411813B (zh) * | 2007-10-19 | 2011-12-28 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗慢性收缩性心力衰竭药物中的应用 |
CN102309675B (zh) * | 2008-04-18 | 2013-02-27 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗病态窦房结综合征药物中的应用 |
CN101559162B (zh) * | 2008-04-18 | 2012-04-18 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗缓慢型心律失常药物中的应用 |
CN102309674B (zh) * | 2008-04-18 | 2014-01-29 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗房室传导阻滞药物中的应用 |
CN101559161B (zh) * | 2008-04-18 | 2010-12-08 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗抑郁症药物中的应用 |
CN101590178B (zh) * | 2008-05-28 | 2012-11-28 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗高龄患者顽固性早搏药物中的应用 |
CN101698052B (zh) * | 2008-05-28 | 2012-05-23 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗急性心肌梗塞合并心律失常药物中的应用 |
CN101698050B (zh) * | 2008-05-28 | 2012-06-27 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗阵发性心房颤动药物中的应用 |
CN103751520A (zh) * | 2008-06-20 | 2014-04-30 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗失眠药物中的应用 |
CN101632781B (zh) * | 2008-07-21 | 2012-09-05 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗干眼症药物中的应用 |
RU2463070C1 (ru) * | 2008-07-23 | 2012-10-10 | Хэбэй Илин Медицин Рисёч Инститьют Ко., Лтд. | Фармацевтическая композиция для регуляции калиевых каналов в клетке сердечной мышцы, способ ее получения и ее применения |
CN101653547B (zh) * | 2008-08-22 | 2012-08-01 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备预防心律失常药物中的应用 |
CN101653546B (zh) * | 2008-08-22 | 2012-11-28 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗风湿性心脏病药物中的应用 |
CN101653548B (zh) * | 2008-08-22 | 2012-10-17 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗低血压药物中的应用 |
CN101366910B (zh) * | 2008-09-11 | 2010-11-03 | 刘运波 | 一种治疗频发早搏的中药 |
CN101683458B (zh) * | 2008-09-23 | 2012-09-05 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗眩晕药物中的应用 |
CN101683459B (zh) * | 2008-09-23 | 2013-02-27 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗睡眠障碍药物中的应用 |
CN102038856B (zh) * | 2009-10-13 | 2012-09-05 | 北京以岭药业有限公司 | 一种中药组合物中四种成分的含量测定方法 |
CN102210806A (zh) * | 2010-04-08 | 2011-10-12 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗非器质性心脏病性心律失常药物中的应用 |
CN102380030B (zh) * | 2010-09-03 | 2014-08-20 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗中暑药物中的应用 |
CN102652799B (zh) * | 2011-03-03 | 2016-03-02 | 北京以岭药业有限公司 | 一种中药组合物的水提液精制方法 |
CN103623207A (zh) * | 2012-08-23 | 2014-03-12 | 石家庄以岭药业股份有限公司 | 一种中药组合物在制备治疗慢性心衰伴心律失常的药物中的应用 |
CN103623206A (zh) * | 2012-08-23 | 2014-03-12 | 石家庄以岭药业股份有限公司 | 一种中药组合物在制备治疗窦性心动过缓伴早搏的药物中的应用 |
CN103675168B (zh) * | 2012-09-08 | 2016-04-06 | 河北以岭医药研究院有限公司 | 一种养心中药制剂指纹图谱的测定方法 |
CN103720859B (zh) * | 2013-12-31 | 2015-11-04 | 齐洪涛 | 一种治疗频发室性早搏的中草药的制作方法 |
CN103834540A (zh) * | 2014-02-26 | 2014-06-04 | 哈尔滨膳宝酒业有限公司 | 一种酸浆强心健脑酒及生产方法 |
CN104914173B (zh) * | 2014-03-14 | 2018-08-28 | 河北以岭医药研究院有限公司 | 一种中药组合物制剂中多种成分含量的测定方法 |
CN104825782A (zh) * | 2015-05-13 | 2015-08-12 | 陕西摩美得制药有限公司 | 一种中药组合物在制备钾离子通道调节剂药物中的应用 |
CN105012748A (zh) * | 2015-08-07 | 2015-11-04 | 李强 | 一种治疗胸痹心痛的中药组合物 |
CN105055565A (zh) * | 2015-08-13 | 2015-11-18 | 王莉 | 治疗冠心病的护理辅助用药及其制法与检测方法及用途 |
CN105079442A (zh) * | 2015-09-21 | 2015-11-25 | 成都艾比科生物科技有限公司 | 一种应用于参松养心胶囊试生产中的提取工艺 |
-
2002
- 2002-10-24 CN CNB02146572XA patent/CN1188159C/zh not_active Expired - Lifetime
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101632784B (zh) * | 2008-07-21 | 2012-09-05 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗急性心梗药物中的应用 |
WO2010009573A1 (zh) * | 2008-07-23 | 2010-01-28 | 河北以岭医药研究院有限公司 | 心肌细胞钾离子通道调节药物组合物及其制备方法和应用 |
KR101298787B1 (ko) * | 2008-07-23 | 2013-08-22 | 허베이 이링 메디슨 리서치 인스티튜트 코오포레이션 리미티드 | 심근 세포 내에서 포타슘 채널을 조절하기 위한 약학 조성물 및 이의 제조방법 및 용도 |
CN101874869B (zh) * | 2009-04-28 | 2012-02-08 | 河北以岭医药研究院有限公司 | 一种中药组合物中马钱苷的含量测定方法 |
CN105928365A (zh) * | 2016-05-05 | 2016-09-07 | 武汉拓材科技有限公司 | 一种用于高纯材料制备的石英器皿渗碳装置及方法 |
CN105928365B (zh) * | 2016-05-05 | 2017-12-12 | 武汉拓材科技有限公司 | 一种用于高纯材料制备的石英器皿渗碳装置及方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1403148A (zh) | 2003-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1188159C (zh) | 一种治疗冠心病室性早搏的药物组合物及制备方法 | |
CN1186071C (zh) | 一种治疗慢性心衰的药物组合物及制备方法 | |
CN1124153C (zh) | 一种治疗冠心病心绞痛的药物组合物 | |
CN101732683A (zh) | 一种治疗面部黄褐斑的中药制剂及其制备方法 | |
CN1162171C (zh) | 治疗妇科疾病的中药 | |
CN1485083A (zh) | 甲状腺癌瘤淋巴结胶囊 | |
CN1742939A (zh) | 一种治疗肺间质纤维化的药物及其制备方法 | |
CN100342891C (zh) | 一种治疗高血压的药物组合物及其制备方法 | |
CN103301426A (zh) | 通脉利心胶囊 | |
CN1255181C (zh) | 一种养正消积药物组合物制剂及制备方法 | |
CN101953918B (zh) | 一种治疗心脑血管疾病的中药组合物 | |
CN1814208A (zh) | 治疗并防止口腔溃疡复发的口服中药 | |
CN103142865A (zh) | 一种治疗高血压的中药 | |
CN101496892B (zh) | 一种治疗心脑血管疾病的口服中成药 | |
CN101036708A (zh) | 治疗心脑血管疾病的药物组合物 | |
CN1067901C (zh) | 治疗偏头痛的药物及其制作方法 | |
CN102204978B (zh) | 一种治疗癌性疼痛的药物组合物及其制剂 | |
CN1943756A (zh) | 一种治疗高血压的中药组合物及其制备方法 | |
CN1692938A (zh) | 一种用于明目的中药复方制剂及其制备方法 | |
CN103272176A (zh) | 一种治疗心血管疾病的中药组合物及其制备方法 | |
CN1183936C (zh) | 一种治疗高血压病的药物及其茶剂制备方法 | |
CN111000969A (zh) | 一种治疗单纯性肥胖的药物组合物及制备方法 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN1943755A (zh) | 一种治疗高血压的中药组合物及其制备方法 | |
CN1245197C (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHIJIAZHUANG YILING MEDICINE CO., LTD. Free format text: FORMER OWNER: HEBEI YILING MEDICINE INST. CO., LTD. Effective date: 20080516 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080516 Address after: No. 238 Tianshan Avenue, Shijiazhuang Patentee after: Shijiazhuang Yiling Pharmaceutical Co.,Ltd. Address before: Xinshi North Road, Shijiazhuang Development Zone, Hebei Province, No. 385 Patentee before: HEBEI YILING MEDICINE RESEARCH INSTITUTE Co.,Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090213 Address after: No. 19, Tianhe West Road, Beijing biological engineering and pharmaceutical industry base, Huangcun Town, Beijing, Daxing District Patentee after: BEIJING YILING PHARMACEUTICAL Co.,Ltd. Address before: No. 238 Tianshan Avenue, Shijiazhuang Patentee before: Shijiazhuang Yiling Pharmaceutical Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING YILING PHARMACY CO., LTD. Free format text: FORMER OWNER: SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Effective date: 20090213 |
|
CX01 | Expiry of patent term |
Granted publication date: 20050209 |
|
CX01 | Expiry of patent term |